Skip to main content
Erschienen in: Neurological Sciences 4/2022

27.10.2021 | Original Article

Atrial cardiopathy predicts detection of atrial fibrillation in embolic stroke of undetermined source: real-life data

verfasst von: Ana Rita Silva, Carla Pires, Filipa Meira-Carvalho, Mariana Santos, Nuno Pimenta Antunes, José Nuno Alves, Carla Ferreira, João Pinho

Erschienen in: Neurological Sciences | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Atrial cardiopathy (AC) is more frequent in patients with embolic stroke of undetermined source (ESUS) than in patients with non-cardioembolic stroke. The aim of this work was to describe AC in patients with ESUS and to study its impact on detection of atrial fibrillation (AF) during follow-up.

Methods

This is an observational study of 123 consecutive ESUS patients and 55 ESUS patients from a previous cohort. AC was defined according to the presence of one or more of the following criteria: severe left atrial enlargement, p-wave terminal force in lead V1 > 5000 μVxms, and excessive premature atrial complexes. Unadjusted and adjusted survival analyses for the occurrence of AF and stroke or transient ischemic attack (TIA) were performed. Diagnostic performance of AC for the detection of AF was analyzed.

Results

Among 178 patients with ESUS, those with AC (42.7%) were older (p < 0.001), and more frequently had hypertension (p = 0.001) and lower total cholesterol levels (p = 0.001) than patients without AC. The detection of AF during follow-up (median 34 months, interquartile range = 12.8–64) was higher in patients with AC (hazard ratio = 7.00, 95% confidence interval = 2.01–24.39, p = 0.002). This association persisted after adjusting for age, arterial hypertension, and other vascular risk factors. The c-statistic for detection of AF during follow-up for AC was 0.719. There were no differences in stroke or TIA recurrence between groups with and without AC.

Discussion

ESUS patients with AC have different baseline clinical characteristics than patients without AC and have a higher detection of AF during follow-up.
Literatur
1.
Zurück zum Zitat Hart RG, Catanese L, Perera KS et al (2017) Embolic stroke of undetermined source: a systematic review and clinical update. Stroke 48:867–872CrossRef Hart RG, Catanese L, Perera KS et al (2017) Embolic stroke of undetermined source: a systematic review and clinical update. Stroke 48:867–872CrossRef
2.
Zurück zum Zitat Hart RG, Diener HC, Coutts SB et al (2014) Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 13:429–438CrossRef Hart RG, Diener HC, Coutts SB et al (2014) Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 13:429–438CrossRef
3.
Zurück zum Zitat Kamel H, Bartz TM, Elkind MSV et al (2018) Atrial cardiopathy and the risk of ischemic stroke in the CHS (Cardiovascular Health Study). Stroke 49:980–986CrossRef Kamel H, Bartz TM, Elkind MSV et al (2018) Atrial cardiopathy and the risk of ischemic stroke in the CHS (Cardiovascular Health Study). Stroke 49:980–986CrossRef
4.
Zurück zum Zitat Kamel H, Okin PM, Elkind MSV et al (2016) Atrial fibrillation and mechanisms of stroke: time for a new model. Stroke 47:895–900CrossRef Kamel H, Okin PM, Elkind MSV et al (2016) Atrial fibrillation and mechanisms of stroke: time for a new model. Stroke 47:895–900CrossRef
5.
Zurück zum Zitat Jalini S, Rajalingam R, Nisenbaum R et al (2019) Atrial cardiopathy in patients with embolic strokes of unknown source and other stroke etiologies. Neurology 92:288–294CrossRef Jalini S, Rajalingam R, Nisenbaum R et al (2019) Atrial cardiopathy in patients with embolic strokes of unknown source and other stroke etiologies. Neurology 92:288–294CrossRef
6.
Zurück zum Zitat Pinho J, Braga CG, Rocha S et al (2015) Atrial ectopic activity in cryptogenic ischemic stroke and TIA: A risk factor for recurrence. J Stroke Cerebrovasc Dis 24:507–510CrossRef Pinho J, Braga CG, Rocha S et al (2015) Atrial ectopic activity in cryptogenic ischemic stroke and TIA: A risk factor for recurrence. J Stroke Cerebrovasc Dis 24:507–510CrossRef
7.
Zurück zum Zitat Diener HC, Sacco RL, Easton JD et al (2019) Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med 380:1906–1917CrossRef Diener HC, Sacco RL, Easton JD et al (2019) Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med 380:1906–1917CrossRef
8.
Zurück zum Zitat Hart RG, Sharma M, Mundl H et al (2018) Rivaroxaban for stroke prevention after emboli stroke of undetermined source. N Engl J Med 378:2191–2201CrossRef Hart RG, Sharma M, Mundl H et al (2018) Rivaroxaban for stroke prevention after emboli stroke of undetermined source. N Engl J Med 378:2191–2201CrossRef
9.
Zurück zum Zitat Kamel H, Merkler AE, Iadecola C et al (2019) Tailoring the approach of embolic stroke of undetermined source: a review. JAMA Neurol 76:855–861CrossRef Kamel H, Merkler AE, Iadecola C et al (2019) Tailoring the approach of embolic stroke of undetermined source: a review. JAMA Neurol 76:855–861CrossRef
10.
Zurück zum Zitat Smietana J, Plitt A, Halperin JL (2019) Thromboembolism in the absence of atrial fibrillation. Am J Cardiol 124:303–311CrossRef Smietana J, Plitt A, Halperin JL (2019) Thromboembolism in the absence of atrial fibrillation. Am J Cardiol 124:303–311CrossRef
11.
Zurück zum Zitat Healey JS, Gladstone DJ, Swaminathan B et al (2019) Recurrent stroke with rivaroxaban compared with aspirin according to predictors of atrial fibrillation: secondary analysis of the NAVIGATE ESUS randomized clinical trial. JAMA Neurol 76:764–773CrossRef Healey JS, Gladstone DJ, Swaminathan B et al (2019) Recurrent stroke with rivaroxaban compared with aspirin according to predictors of atrial fibrillation: secondary analysis of the NAVIGATE ESUS randomized clinical trial. JAMA Neurol 76:764–773CrossRef
12.
Zurück zum Zitat Kamel H, Jr WTL, Tirschwell DL, et al. (2018) The atrial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke randomized trial : rationale and methods. 14:207-214 Kamel H, Jr WTL, Tirschwell DL, et al. (2018) The atrial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke randomized trial : rationale and methods. 14:207-214
13.
Zurück zum Zitat Perlepe K, Sirimarco G, Strambo D et al (2020) Left atrial diameter thresholds and new incident atrial fibrillation in embolic stroke of undetermined source. Eur J Intern Med 75:30–34CrossRef Perlepe K, Sirimarco G, Strambo D et al (2020) Left atrial diameter thresholds and new incident atrial fibrillation in embolic stroke of undetermined source. Eur J Intern Med 75:30–34CrossRef
14.
Zurück zum Zitat Elkind MS (2018) Atrial cardiopathy and stroke prevention. Current cardiology reports 20(11):1-14.15CrossRef Elkind MS (2018) Atrial cardiopathy and stroke prevention. Current cardiology reports 20(11):1-14.15CrossRef
15.
Zurück zum Zitat Rasmussen SMA, Olsen FJ, Jørgensen PG, Fritz-Hansen T, Jespersen T, Gislason G, Biering-Sørensen T (2019) Utility of left atrial strain for predicting atrial fibrillation following ischemic stroke. Int J Cardiovasc Imaging 35(9):1605–1613CrossRef Rasmussen SMA, Olsen FJ, Jørgensen PG, Fritz-Hansen T, Jespersen T, Gislason G, Biering-Sørensen T (2019) Utility of left atrial strain for predicting atrial fibrillation following ischemic stroke. Int J Cardiovasc Imaging 35(9):1605–1613CrossRef
Metadaten
Titel
Atrial cardiopathy predicts detection of atrial fibrillation in embolic stroke of undetermined source: real-life data
verfasst von
Ana Rita Silva
Carla Pires
Filipa Meira-Carvalho
Mariana Santos
Nuno Pimenta Antunes
José Nuno Alves
Carla Ferreira
João Pinho
Publikationsdatum
27.10.2021
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 4/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-021-05692-3

Weitere Artikel der Ausgabe 4/2022

Neurological Sciences 4/2022 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.